EPISODE · Jun 1, 2011 · 14 MIN
Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease
from Lipid Luminations
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Christie Ballantyne, MD Dr. Christie Ballantyne discusses with host Dr. Alan Brown the use of genetic testing in various phases of disease onset in patients facing heart disease. They talk about how clinicians can utilize the current technologies, what the costs are and the benefits. How does learning more about the genetic mutation behind familial hypercholesterolemia affect treatment? Dr. Ballantyne and Dr. Brown also discuss what new genetic testing techniques are on the horizon. Brought to you by:
Embed this episode
NOW PLAYING
Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease
No transcript for this episode yet
Similar Episodes
No similar episodes found.